These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 10480671)

  • 1. The prolactin response to fenfluramine in schizophrenia is associated with negative symptoms.
    Sharma RP; Singh V; Janicak PG; Javaid JI; Pandey GN
    Schizophr Res; 1999 Aug; 39(1):85-9. PubMed ID: 10480671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolactin response to D-fenfluramine challenge test as a predictor of treatment response to haloperidol in acute schizophrenia.
    Mohr P; Horácek J; Motlová L; Libiger J; Czobor P
    Schizophr Res; 1998 Feb; 30(1):91-9. PubMed ID: 9542792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolactin hyperresponsiveness to D-fenfluramine in drug-free schizophrenic patients: a placebo-controlled study.
    Monteleone P; Tortorella A; Borriello R; Cassandro P; Maj M
    Biol Psychiatry; 1999 Jun; 45(12):1606-11. PubMed ID: 10376122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prolactin response to fenfluramine in depression: effects of melancholia and baseline cortisol.
    Mulder RT; Porter RJ; Joyce PR
    J Psychopharmacol; 2003 Mar; 17(1):97-102. PubMed ID: 12680745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-HT neuroendocrine function in major depression: prolactin and cortisol responses to D-fenfluramine.
    Park SB; Williamson DJ; Cowen PJ
    Psychol Med; 1996 Nov; 26(6):1191-6. PubMed ID: 8931165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolactin and cortisol responses to d-fenfluramine in major depression: evidence for diminished responsivity of central serotonergic function.
    O'Keane V; Dinan TG
    Am J Psychiatry; 1991 Aug; 148(8):1009-15. PubMed ID: 1853948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of the prolactin response to d-fenfluramine in drug-naive schizophrenic patients.
    Abel KM; O'Keane V; Murray RM
    Br J Psychiatry; 1996 Jan; 168(1):57-60. PubMed ID: 8770429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depression in premenopausal women: gonadal hormones and serotonergic system assessed by D-fenfluramine challenge test.
    Rajewska J; Rybakowski JK
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Jun; 27(4):705-9. PubMed ID: 12787860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of fenfluramine on prolactin secretion in obese patients: evidence for serotoninergic regulation of prolactin in man.
    Barbieri C; Magnoni V; Rauhe WG; Zanasi S; Caldara R; Ferrari C
    Clin Endocrinol (Oxf); 1983 Dec; 19(6):705-10. PubMed ID: 6360431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of fenfluramine on sleep and prolactin in depressed inpatients: a comparison of potential indices of brain serotonergic responsivity.
    Myers JE; Buysse DJ; Thase ME; Perel J; Miewald JM; Cooper TB; Kupfer DJ; Mann JJ
    Biol Psychiatry; 1993 Dec; 34(11):753-8. PubMed ID: 8292678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of haloperidol treatment on prolactin response to D-fenfluramine challenge in acute schizophrenia.
    Mohr P; Horácek J; Motlová L; Libiger J; Czobor P
    Psychopharmacology (Berl); 1999 Jan; 141(3):322-5. PubMed ID: 10027514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma prolactin, adrenocorticotrophic hormone and cortisol after administration of d-fenfluramine or placebo to healthy subjects.
    Gorard DA; Taylor TM; Medbak SH; Perry LA; Libby GW; Farthing MJ
    Int Clin Psychopharmacol; 1993; 8(2):123-8. PubMed ID: 8393895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormonal responses to fenfluramine in depressive subtypes.
    Mitchell P; Smythe G; Parker G; Wilhelm K; Hickie I; Brodaty H; Boyce P
    Br J Psychiatry; 1990 Oct; 157():551-7. PubMed ID: 2131137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The fenfluramine challenge test in the affective spectrum: a possible marker of endogeneity and severity.
    López-Ibor JJ; Saiz-Ruiz J; Iglesias LM
    Pharmacopsychiatry; 1988 Jan; 21(1):9-14. PubMed ID: 3283785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroendocrine and behavioral responses to challenge with the indirect serotonin agonist dl-fenfluramine in adults with obsessive-compulsive disorder.
    McBride PA; DeMeo MD; Sweeney JA; Halper J; Mann JJ; Shear MK
    Biol Psychiatry; 1992 Jan; 31(1):19-34. PubMed ID: 1311964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolactin response to fenfluramine and suicide attempt lethality in major depression.
    Malone KM; Corbitt EM; Li S; Mann JJ
    Br J Psychiatry; 1996 Mar; 168(3):324-9. PubMed ID: 8833686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolactin response to fenfluramine in abstinent, alcohol-dependent patients.
    Porter RJ; Sellman D; Joyce PR; Davies J; Frampton C
    Addict Biol; 2008 Sep; 13(3-4):380-5. PubMed ID: 18279498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocrine and amine responses to D,L-fenfluramine in normal subjects.
    Mitchell PB; Smythe GA
    Psychiatry Res; 1991 Nov; 39(2):141-53. PubMed ID: 1686811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonergic regulation of prolactin and growth hormone secretion in man.
    Lewis DA; Sherman BM
    Acta Endocrinol (Copenh); 1985 Oct; 110(2):152-7. PubMed ID: 4060968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral D-fenfluramine and neuroendocrine challenge: problems with the 30 mg dose in men.
    Goodwin GM; Murray CL; Bancroft J
    J Affect Disord; 1994 Feb; 30(2):117-22. PubMed ID: 8201126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.